Target intelligence / Profile preview

Synaptic vesicle of dopaminergic neuron

Molecular classification
Other (organelle/subcellular compartment)
01

Overview

Synaptic vesicles of dopaminergic neurons are small, membrane-bound organelles located in the axon terminals of dopamine-producing neurons. They act as storage reservoirs for dopamine, which is accumulated within vesicles chiefly through VMAT2. Upon arrival of an action potential and subsequent calcium influx, SNARE proteins mediate vesicle fusion with the presynaptic membrane, leading to exocytotic release of dopamine into the synaptic cleft. Dysregulation of vesicular dopamine cycling is linked to the pathophysiology of neurodegenerative and neuropsychiatric diseases such as Parkinson’s disease. Although the vesicle itself is not a direct molecular target for drug development, its constituent proteins, such as VMAT2, are established pharmacological targets[1][2][3][5][7].

Other names
Dopaminergic synaptic vesicleDopamine storage vesiclePresynaptic dopamine vesicle
02

Mechanism of action

Not direct. Mechanisms relevant to vesicle function include: Inhibition of VMAT2 (depletes vesicular dopamine, as with tetrabenazine); Promotion of vesicle release or inhibition of dopamine reuptake (as with amphetamines or cocaine).

03

Biological functions

Neurotransmitter storageSynaptic neurotransmitter releaseDopamine trafficking
04

Disease associations

Neurodegenerative disease (especially Parkinson’s disease)Psychiatric disease (implicated in disorders involving dopamine signaling)
05

Safety considerations

Drugs interfering with vesicular dopamine management can cause severe neuropsychiatric or movement disorders (e.g., tetrabenazine-induced depression or parkinsonism)
06

Interacting drugs

Indirectly: Drugs targeting VMAT2 (e.g., tetrabenazine) or DAT (e.g., cocaine, methylphenidate, amphetamines)
07

Biomarkers

Vesicular monoamine transporter 2 (VMAT2, SLC18A2)Tyrosine hydroxylase (dopaminergic neuron marker—indirect)DAT (dopamine transporter—indirect)

Beyond the preview

Go deeper on Synaptic vesicle of dopaminergic neuron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptic vesicle of dopaminergic neuron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call